Close Menu

NEW YORK (GenomeWeb) — NanoView Biosciences said today that it has closed a $10 million Series B round of financing.

The round was led by Northpond Ventures and included existing investors Sands Capital Ventures and PBM Capital Group.

Boston-based NanoView said it will use the funding to complete development of its ExoView system for the characterization of exosomes and other extracellular vesicles, as well as prepare for the product's commercial launch in early 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.